Evidence map›Paper›PMID 39876002›Full record

ArticleJournal of experimental & clinical cancer research : CR2025

E. Coli cytotoxic necrotizing factor-1 promotes colorectal carcinogenesis by causing oxidative stress, DNA damage and intestinal permeability alteration.

Michela Tozzi, Alessia Fiore, Sara Travaglione, Francesca Marcon, Gabriella Rainaldi, Elena Angela Pia Germinario, Ilenia Laterza, Simona Donati, Daniele Macchia, Massimo Spada and 26 more

Abstract read
In one paragraph

Article in Journal of experimental & clinical cancer research : CR, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. The intersection of colorectal cancer and cardiovascular disease: shared mechanisms and clinical implications.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  2. Review
  3. Review
  4. Phenotypic and Genomic Profiling ofAntibiotics (Basel, Switzerland) · 2026
    Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors.

Michela Tozzi *Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
Alessia Fiore *Department of Cardiovascular, Endocrine-Metabolic Diseases and Aging, Istituto Superiore di Sanità, Rome, Italy.
Sara TravaglioneDepartment of Cardiovascular, Endocrine-Metabolic Diseases and Aging, Istituto Superiore di Sanità, Rome, Italy.
Francesca MarconDepartment of Environment and Health, Istituto Superiore di Sanità, Rome, Italy.
Gabriella RainaldiDepartment of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
Elena Angela Pia GerminarioDepartment of Cardiovascular, Endocrine-Metabolic Diseases and Aging, Istituto Superiore di Sanità, Rome, Italy.
Ilenia LaterzaDepartment of Cardiovascular, Endocrine-Metabolic Diseases and Aging, Istituto Superiore di Sanità, Rome, Italy.
Simona DonatiDepartment of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
Daniele MacchiaCenter of Animal Research and Welfare, Istituto Superiore di Sanità, Rome, Italy.
Massimo SpadaCenter of Animal Research and Welfare, Istituto Superiore di Sanità, Rome, Italy.
Omar LeoniCenter of Animal Research and Welfare, Istituto Superiore di Sanità, Rome, Italy.
Maria Cristina QuattriniCore Facilities, Istituto Superiore di Sanità, Rome, Italy.
Donatella PietraforteCore Facilities, Istituto Superiore di Sanità, Rome, Italy.
Sofia TomasoniDepartment of Comparative Biomedicine and Food Science, BCA-University of Padua, Legnaro, PD, Italy.
Filippo TorrigianiDepartment of Comparative Biomedicine and Food Science, BCA-University of Padua, Legnaro, PD, Italy.
Ranieri VerinDepartment of Comparative Biomedicine and Food Science, BCA-University of Padua, Legnaro, PD, Italy.
Paola MatarreseCenter for Gender-Specific Medicine, Istituto Superiore di Sanità, Rome, Italy.
Lucrezia GambardellaCenter for Gender-Specific Medicine, Istituto Superiore di Sanità, Rome, Italy.
Francesca SpadaroCore Facilities, Istituto Superiore di Sanità, Rome, Italy.
Maria CarolloCore Facilities, Istituto Superiore di Sanità, Rome, Italy.
Agostina PietrantoniCore Facilities, Istituto Superiore di Sanità, Rome, Italy.
Francesca CarliniDepartment of Cardiovascular, Endocrine-Metabolic Diseases and Aging, Istituto Superiore di Sanità, Rome, Italy.
Concetta PanebiancoDivision of Gastroenterology, Fondazione IRCCS "Casa Sollievo della Sofferenza", San Giovanni Rotondo, FG, Italy.
Valerio PazienzaDivision of Gastroenterology, Fondazione IRCCS "Casa Sollievo della Sofferenza", San Giovanni Rotondo, FG, Italy.
Filomena ColellaMultiplex Spatial Profiling Center, Fondazione Policlinico Universitario "A. Gemelli" - IRCCS, Rome, Italy.
Donatella LucchettiMultiplex Spatial Profiling Center, Fondazione Policlinico Universitario "A. Gemelli" - IRCCS, Rome, Italy.
Alessandro SgambatoMultiplex Spatial Profiling Center, Fondazione Policlinico Universitario "A. Gemelli" - IRCCS, Rome, Italy.
Antonella SistiguDepartment of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore, Rome, Italy.
Federica MoschellaDepartment of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
Marco GuidottiDepartment of Food Safety, Nutrition and Veterinary Public Health, Istituto Superiore di Sanità, Rome, Italy.
Olimpia VincentiniDepartment of Food Safety, Nutrition and Veterinary Public Health, Istituto Superiore di Sanità, Rome, Italy.
Zaira MarocciaDepartment of Cardiovascular, Endocrine-Metabolic Diseases and Aging, Istituto Superiore di Sanità, Rome, Italy.
Mauro BiffoniDepartment of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
Roberta De AngelisDepartment of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
Laura Bracci *Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy. laura.bracci@iss.it.
Alessia Fabbri *Department of Cardiovascular, Endocrine-Metabolic Diseases and Aging, Istituto Superiore di Sanità, Rome, Italy.

Funding

Associazione Italiana per la Ricerca sul Cancro IG 2019 - ID 23006 projectNextGenerationEU PNRR - M4C2-I1.3 Project PE_00000019 "HEAL ITALIA"
6 · The paper itself

Abstract

backgroundBacterial toxins are emerging as promising hallmarks of colorectal cancer (CRC) pathogenesis. In particular, Cytotoxic Necrotizing Factor 1 (CNF1) from E. coli deserves special consideration due to the significantly higher prevalence of this toxin gene in CRC patients with respect to healthy subjects, and to the numerous tumor-promoting effects that have been ascribed to the toxin in vitro. Despite this evidence, a definitive causal link between CNF1 and CRC was missing. Here we investigated whether CNF1 plays an active role in CRC onset by analyzing pro-carcinogenic key effects specifically induced by the toxin in vitro and in vivo.

methodsViability assays, confocal microscopy of γH2AX and 53BP1 molecules and cytogenetic analysis were carried out to assess CNF1-induced genotoxicity on non-neoplastic intestinal epithelial cells. Caco-2 monolayers and 3D Caco-2 spheroids were used to evaluate permeability alterations specifically induced by CNF1, either in the presence or in the absence of inflammation. In vivo, an inflammatory bowel disease (IBD) model was exploited to evaluate the carcinogenic potential of CNF1. Immunohistochemistry and immunofluorescence stainings of formalin-fixed paraffin-embedded (FFPE) colon tissue were carried out as well as fecal microbiota composition analysis by 16 S rRNA gene sequencing.

resultsCNF1 induces the release of reactive oxidizing species and chromosomal instability in non-neoplastic intestinal epithelial cells. In addition, CNF1 modifies intestinal permeability by directly altering tight junctions' distribution in 2D Caco-2 monolayers, and by hindering the differentiation of 3D Caco-2 spheroids with an irregular arrangement of these junctions. In vivo, repeated intrarectal administration of CNF1 induces the formation of dysplastic aberrant crypt foci (ACF), and produces the formation of colorectal adenomas in an IBD model. These effects are accompanied by the increased neutrophilic infiltration in colonic tissue, by a mixed pro-inflammatory and anti-inflammatory cytokine milieu, and by the pro-tumoral modulation of the fecal microbiota.

conclusionsTaken together, our results support the hypothesis that the CNF1 toxin from E. coli plays an active role in colorectal carcinogenesis. Altogether, these findings not only add new knowledge to the contribution of bacterial toxins to CRC, but also pave the way to the implementation of current screening programs and preventive strategies.

Indexed as

Bacterial ToxinsColorectal NeoplasmsDNA DamageEscherichia coli ProteinsOxidative StressAnimalsCaco-2 CellsCarcinogenesisEscherichia coliHumansIntestinal Barrier FunctionIntestinal MucosaMicePermeabilityBacterial Toxinscytotoxic necrotizing factor type 1Escherichia coli Proteins3D Caco-2 spheroidsCNF1Colorectal cancerDNA damageEscherichia coliGenotoxicityImmune infiltratesInflammationIntestinal permeabilityOxidative stress

Identifiers

PMID39876002
PMCPMC11776187

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.